Markets › Stocks › VISTAPH
VI

Vista Pharmaceuticals Ltd.

NSE: VISTAPHBSE: 524711Healthcare
Download Research Report7-page PDF
₹7.70
▲ +2.94%
NSE · auto-updates while market open
Mkt Cap
₹9 Cr
P / E
-
P / B
0.3
ROE
-29.5%
52W High
₹12.01
52W Low
₹5.71
Key Metrics
Market Cap
₹9 Cr
P / E
-
P / B
0.26
EV / EBITDA
-
ROCE
-30.3%
ROE
-29.5%
Debt / Equity
0.27
Book Value
₹29.60
EPS
-
Div Yield
0.0%
Face Value
-
Promoter Holding
21.2%
Revenue · ₹ Cr
0
FY22
1
FY23
10
FY24
10
FY25
5
FY26
Net Profit · ₹ Cr
-1
-6
-5
-5
-12
FY22FY23FY24FY25FY26
EPS · ₹ per share
₹-0.2
₹-1.6
₹-1.0
FY22FY23FY24
Q1 2026 snapshot
Sales
₹0 Cr
Operating profit
-
OPM
-
Net profit
₹-6 Cr
EPS
-
Scorecard · 7 axes
Quality
Weak
42/100
Valuation
-
Growth
Strong
+46.2%
Profitability
Bad
-29.9%
Performance
Bad
-31.7%
Entry Point
Good
64%
Red Flags
Strong
0 flags
Shareholding Pattern
21.2%Promoter
Promoter21.2%
DII0.0%
Public78.8%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue2.683.471.521.652.510.03
Net Profit-1.322-1.496-1.29-2.589-2.319-5.863
NPM %-49.3%-43.1%-84.9%-156.9%-92.4%-19543.3%
AlertPre-trade